Alendronate Tablet
NDC Package 60723-207-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Alendronate (alendronate sodium) tablets is alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. This formulation utilizes a tablet delivery system. Marketed by Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd., this product is identified by NDC 60723-207 and is authorized under FDA application ANDA090258.

Identification & Billing

NDC Package Code
60723-207-01
Package Description
1 BAG in 1 CASE / 80000 TABLET in 1 BAG
Product Code
60723-207
11-Digit Billing Format
60723020701
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Alendronate
Non-Proprietary Name
Alendronate Sodium
Substance Name
Alendronate Sodium
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates.

Regulatory & Marketing

Labeler Name
Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.
Product Type
Human Prescription Drug
FDA Application #
ANDA090258
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-05-2017
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (60723-207). Click a package code to view its specific billing and regulatory data.

60723-207-31
1 BLISTER PACK in 1 CARTON / 4 TABLET in 1 BLISTER PACK
60723-207-32
3 BLISTER PACK in 1 CARTON / 4 TABLET in 1 BLISTER PACK
60723-207-33
2 BLISTER PACK in 1 CARTON / 10 TABLET in 1 BLISTER PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 60723-207-01 identifies a specific commercial package of 1 bag in 1 case / 80000 tablet in 1 bag of Alendronate, a human prescription drug labeled by Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.. This tablet is formulated for oral use and contains alendronate sodium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. on December 05, 2017. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates.

How is this Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 60723020701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
60723-207-01
11-Digit CMS (5-4-2)
60723-0207-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.